Updates in Urologic Oncology Latest Articles

• The information presented in the Updates in Urologic Oncology eNewsletter is provided for physicians and other healthcare providers only and should not be shared with any current or future patients. If you are not a healthcare provider, we welcome you to sign up for Thrive eNewsletter to receive the latest information and blog highlights from Fox Chase Cancer Center.

  

  
      A Fox Chase Cancer Center publication for physicians

   

   

  Winter 2024

  Adstiladrin (Nadofaragene Firadenovec-vncg): The First Intravesical Gene Therapy for Bladder Cancer Now Available at Fox Chase 

  Voting Is Now Open for 2024–2025 U.S. News & World Report Best Hospitals 

  Meet the Navigators to Complex, Coordinated, Compassionate GU Cancer Care 

  Recognizing International Excellence 

  Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

  ---

  Fall 2024 

  Ending the Reliance on BCG 

  Fox Chase Cancer Center Welcomes Dr. J. Ryan Mark 

  Register Now: Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies 

  Researchers Identify Where to Target Interventions to Reduce Disparities in Aggressive Prostate Cancer 

  Fox Chase Cancer Center Opens First New Jersey Location

  Awards and Recognitions for Fox Chase’s Genitourinary Cancer Service Line

  ---

  Fall 2023

  Fox Chase Cancer Center Study Challenges Assumptions About Cystic Renal Masses

  Temple Health Launches New Fox Chase-Temple Urologic Institute

  Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

  Nothing is lost in translation for Russian-speaking patients with urologic cancers

  Study Investigates Hypomethylation Immunotherapy Combination in Bladder Cancer

  ---

  Winter 2023

  New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment

  The New Department of Urology at Fox Chase Cancer Center

  Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment

  Cancer Is a Moving Target. CBCT-Based Adaptive Radiation Therapy Tracks It Every Day of Treatment.

  Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.

  A Salvage Treatment Jennifer Was Inspired to Salvage.
   

  ---

  Fall 2022

  Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer

  Fox Chase Urology Just Took a Big Leap Forward

  Exciting New Leadership for World-Class Growth

  Fox Chase Researchers Examine Racial Differences in Treatment and Outcomes of First-Line Therapies for Kidney Cancer

  Dr. Laura Bukavina on the Front Lines of Research and War

   

  ---

  Winter 2022

  Molecular Profiling Named Top Advance of 2021 by ASCO

  Kutikov Leads International Effort to Optimize Management of Adrenal Masses

  New Prognostic Model More Accurately Predicts Kidney Cancer Recurrence and Survival

  Christine Amoroso Coordinates Treatment-Optimizing, Dedicated Intravesical Clinic

  ---

  Fall 2020

  Fox Chase Now Offering Prostate Micro-Ultrasound Technology

  Surgeon, Mother, Pioneer: Surgical Oncologist Rosalia Viterbo, MD, Is Committed to It All

  Urologic Oncology APC and MD Author Book Chapter on Kidney Cancer

  Fox Chase Welcomes Andres F. Correa, MD

  Fox Chase Offers InPACT Trial for Penile Cancers

   

  ---

  Winter 2020

  Fox Chase Offers InPACT Trial for Penile Cancers

  International Collaborations Help Optimize Partial Nephrectomy Techniques

  Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery

  Research Identifies Predictors of Concern in Post-Treatment Prostate Cancer Patients

  Patient-Reported Quality of Life Research May Guide Treatment Decisions for Lower-Risk Prostate Cancer

  Meet Susan Sippel, Nursing Assistant in Fox Chase’s Urologic Oncology Practice

  ---

  Summer 2019

  Finding More Ways for Bladder Cancer Patients to Keep Their Bladders Through Clinical Trials

  Treating Advanced Renal Cell Carcinoma with a New Drug Combination

  Investigating the Roles of Immune Responses, Bacteria in Curing Bladder Cancer with Chemotherapy

  Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care

  SpaceOAR Hydrogel Reduces Side Effects of Prostate Cancer Radiation Therapy

  Spotlight on Lisa Hicks, RN, BSN, OCN

  ---

  Fall 2018

  Robert Uzzo Receives SUO Medal for Contributions to Urologic Oncology

  Cryosurgery’s Clinical Benefit:
  Delays Needed for Hormone Therapy for Most Men with Locally Recurrent Prostate Cancer

  How to Find the 30 Percent:
  Tackling Diagnostic Challenges Following Muscle Invasive Bladder Cancer Treatment

  Spring 2018 AUA & SUO Presentations

  Surgical Consultations Now Available in Fox Chase’s East Norriton Offices

  Meet Tina Larason: Clinic Coordinator of Fox Chase’s Urologic Oncology Practice

   

  Summer 2018

  Evaluation and Treatment for Adrenal Mass at Fox Chase

   

  Winter 2018

  Urologic Oncology Winter Presentations

  Clinical Trials for Kidney Cancer & Sporadic Renal AMLs

  Fox Chase Urologic Oncologists Serve as Leaders for PURC Collaborative

  The Latest in Imaging and Prostate Biopsy Technology is at Fox Chase

  Checking in with Ben Ristau, Former Fellow in Urologic Oncology

  Fox Chase Proud: Lisa Erickson, Senior Medical Secretary

   

  Fall 2017

  Fox Chase Urologic Oncology Contributions and Accomplishments

  Alexander Kutikov Appointed Chief of the Division of Urologic Oncology at Fox Chase Cancer Center

  Fellow Establishes Urologic Oncology Program in Israel

  Fox Chase Uses Innovative Transperineal Biopsy Technique for Detecting Prostate Cancer to Reduce the Chance of Biopsy-Related Complications

  Phillip Abbosh, MD, PhD, Receives Award from AUA for Bladder Cancer Research

  Robert Uzzo, MD, FACS, Receives Award from Society of Urologic Oncology

  Nurse’s Passion Makes her a Mainstay at Fox Chase